Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells


ABSTRACT: Peripheral T-cell lymphoma unspecified (PTCL/U), the most common form of PTCL, displays heterogeneous morphology and phenotype, poor response to treatment, and dismal prognosis. We demonstrate that PTCL/U shows a gene expression profile clearly distinct from that of normal T-cells. Comparison with the profiles of purified T-cell subpopulations [CD4+, CD8+, resting (HLA-DR-), and activated (HLA-DR+)] reveals that PTCLs/U are most closely related to activated peripheral T-lymphocytes, either CD4+ or CD8+. Interestingly, the global gene expression profile cannot be surrogated by routine CD4/CD8 immunohistochemistry. When compared with normal T-cells, PTCLs/U display deregulation of functional programs often involved in tumorigenesis (e.g. apoptosis, proliferation, cell adhesion, and matrix remodeling). Products of deregulated genes can be detected in PTCLs/U by immunohistochemistry with an ectopic, paraphysiologic or stromal location. Among others, PTCLs/U aberrantly express PDGFRA, a tyrosine-kinase receptor, whose deregulation is often related to a malignant phenotype. Notably, both phosphorylation of PDGFRA and sensitivity of cultured PTCL cells to imatinib (as well as to an inhibitor of histone-deacetylase) are found. These results, which might be extended to other rarer PTCL categories, are provided with implications for tumor pathogenesis and clinical management. Experiment Overall Design: 40 cases of Peripheral T-cell lymphoma (PTCL) were analyzed, including 28 PTCL/unspecified, 6 angioimmunoblastic (AITL) and 6 anaplastic large cell lymphoma cases (ALCL). Frozen lymph-nodes collected at diagnosis (before therapy) were used. In addition, 20 samples of normal T-cells (5 CD4+, 5 CD8+, 5 HLA-DR+, and 5 HLA-DR-) collected from peripheral blood and tonsils of healthy donors were studied. The HG U133 2.0 plus microarray (Affymetrix) was adopted.

ORGANISM(S): Homo sapiens

SUBMITTER: pier paolo piccaluga 

PROVIDER: E-GEOD-6338 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

Piccaluga Pier Paolo PP   Agostinelli Claudio C   Califano Andrea A   Rossi Maura M   Basso Katia K   Zupo Simonetta S   Went Philip P   Klein Ulf U   Zinzani Pier Luigi PL   Baccarani Michele M   Dalla Favera Riccardo R   Pileri Stefano A SA  

The Journal of clinical investigation 20070215 3


Peripheral T cell lymphoma, unspecified (PTCL/U), the most common form of PTCL, displays heterogeneous morphology and phenotype, poor response to treatment, and poor prognosis. We demonstrate that PTCL/U shows a gene expression profile clearly distinct from that of normal T cells. Comparison with the profiles of purified T cell subpopulations (CD4+, CD8+, resting [HLA-DR-], and activated [HLA-DR+]) reveals that PTCLs/U are most closely related to activated peripheral T lymphocytes, either CD4+ o  ...[more]

Similar Datasets

2006-12-25 | GSE6338 | GEO
2013-12-25 | E-GEOD-53633 | biostudies-arrayexpress
2013-12-25 | GSE53633 | GEO
2009-09-22 | E-TABM-783 | biostudies-arrayexpress
2011-03-01 | E-GEOD-20874 | biostudies-arrayexpress
2020-10-22 | PXD015249 | Pride
2022-05-29 | GSE204875 | GEO
2022-05-29 | GSE204876 | GEO
2018-11-09 | GSE122347 | GEO
2015-06-01 | GSE58445 | GEO